Articles

Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN)

Wei Cao 1, Kang Qin 2, Feng Li 3, Wanqing Chen J Natl Cancer Cent. 2024 May 7;4(2):128-134

The International Agency for Research on Cancer (IARC) released the latest estimates of the global burden of cancer. We present a comparison of cancer profiles between 2020 and 2022, leveraging data from the Global Cancer Statistics (GLOBOCAN). Lung cancer remained the most common cancer and the leading cause of ca... Read More

23 Mar, 2026

Global burden of cancer and associated risk factors in 204 countries and territories, 1980– 2021: a systematic analysis for the GBD 2021

Zenghong Wu, Fangnan Xia and Rong Li. Journal of Hematology & Oncology, (2024)

Cancer is the second most common cause of death globally.This study aimed to assess cancer burden and associated risk factors in 204 countries and territories between 1980 and 2021.Methods We selected data on cancer incidence and mortality rates and associated risk factors from the global burden of disease (GBD) st... Read More

23 Mar, 2026

Global Disparities of Cancer and Its Projected Burden in 2050

Habtamu Mellie Bizuayehu, PhD, MPH; Kedir Y. Ahmed, PhD; Getiye Dejenu Kibret, P JAMA

Cancer prevention and care efforts have been challenged by the COVID-19 pandemicand armed conflicts, resulting in a decline in the global Human Development Index (HDI), particularly in low- and middle-income countries. This population-based study included 36 cancer types from 185 countries and territories. By 2050,... Read More

23 Mar, 2026

European cancer mortality predictions for the year 2025 with focus on breast cancer

C. Santucci1, S. Mignozzi1, F. Levi, M. et al. Annals of Oncology Volume 36 - Issue 4 – 2025

We predicted the number of cancer deaths and rates for 2025 in the European Union (EU), its five most populous countries, and the UK, focusing on breast cancer. We estimated 1,280 000 cancer deaths in the EU in 2025, corresponding to age-standardized rates (ASRs) of 120.9/100 000 males and 79.1/100 000 females. In... Read More

23 Mar, 2026

Cancer Statistics, 2026

Rebecca L. Siegel, Tyler B. Kratzer, Nikita Sandeep Wagle, et al. CA Cancer J Clin. 2026;e 70043

In 2026, approximately 2,114,850 new cancer cases and 626,140 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2023, averting 4.8 million deaths since 1991, largely because of smoking reductions, earlier detection, and improved treatment. The 5‐year ... Read More

16 Mar, 2026

The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Cancer Collaborators. Lancet 2025; 406: 1565–86

Cancer is a leading cause of death globally. To inform global cancer-control efforts, we used the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 framework to generate and analyze estimates of cancer burden for 47 cancer types or groupings by age, sex, and 204 countries and territories from 1... Read More

16 Mar, 2026

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Mathieu LaversanneMSc, Hyuna Sung, et al. CA Cancer J Clin. 2024;74:229–263

This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from ... Read More

16 Mar, 2026

The Global Cancer Crisis: A Review of Growing Burden, Deepening Inequality And Initiatives for Prevention and Early Detection

Charles M Balch, Ning Liao, Dennis S C Lam, Jeffrey N Weitzel, et al. ecancer 2026, 20:2071

Cancer constitutes one of the most urgent global health crises, with over 20 million new cases diagnosed annually worldwide, claiming 10 million lives. This devastating burden disproportionately affects vulnerable populations: 75% of cancer deaths occur in low- and middle-income countries despite these regions having l... Read More

16 Mar, 2026